The present invention relates to compounds of formula
wherein R
1
, R
2
, R
3
, R
4
, Z, and n are as defined herein
or to a pharmaceutically active salt thereof. Compounds of the invention are high potential NK-3 receptor antagonists for the treatment of depression, pain, psychosis, Parkinson's disease, schizophrenia, anxiety and attention deficit hyperactivity disorder (ADHD).
[EN] PYRROLIDINE DERIVATIVES<br/>[FR] DÉRIVÉS DE PYRROLIDINE
申请人:HOFFMANN LA ROCHE
公开号:WO2011085886A1
公开(公告)日:2011-07-21
The present invention relates to compounds of formula (I) or to a pharmaceutically active salt thereof. It has been found that the present compounds are high potential NK-3 receptor antagonists for the treatment of depression, pain, psychosis, Parkinson's disease, schizophrenia, anxiety and attention deficit hyperactivity disorder (ADHD).
of α,β-unsaturated methyl ketone/nitro compounds from benzylic amines through an oxidation–aldol/Henry reaction is reported. The reaction proceeded well by using MCPBA as oxidant and CuCl2·2H2O as catalyst. A variety of functionalized α,β-unsaturated methyl ketone/nitro compounds were assembled in moderate yields by application of this catalytic one-pot reaction.